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rhythmias in the VA-ECMO group (16% vs. 50%, p¼0.02).
CONCLUSIONS Both VA-ECMO and p-VAD had similar survival and
complication rates when used in patients presenting with RCS in AMI.
Choice of device in these patients should be based on operator
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BACKGROUND We sought to evaluate the outcomes of ECMO
in a variety of clinical settings among patients presenting in
cardiogenic shock and/or respiratory failure and underwent emer-
gent venous-arterial (VA) ECMO and/or venous-venous (VV) ECMO
placement.
METHODS We retrospectively analyzed data from 163 consecutive
ECMOs (21 VV and 142 VA) at the MH CAHF from 2012 to 2014. Mor-
tality and morbidity at discharge were analyzed in relationship to type
of ECMO support VA vs VV.
RESULTS Overall ECMO survival rates at discharge was 40%, however
signiﬁcant difference in terms of mortality and morbidity was
observed between VA and VV groups. In the VV group the median age
was 50 years (IQR 23,57), average length of stay was 33 days (IQR
22,48) median length of support was 8 days (IQR 3,20). VV mortality
was 19% (4 cases). Causes of death were stroke in 1 patient and mul-
tiorgan failure in 3 patients and death occurred after 2, 29,24,35 days,
respectively, after ECMO implantation. Respiratory failure due to
H1N1 led to ECMO implantation in 4 cases and caused the demise of 2
patients (50% mortality). No hypothermia protocol was utilized.
Vascular complications related to access were reported in 5% of the
patients. Stroke prevalence was 14% and led to patient demise in 1case. The longest length of support with successful weaning was 31
days. In the VA group the median age was 61 years (IQR 48,70),
average length of stay was days 16 days (IQR 7,34) median length of
support was 4 days (IQR 1,7). VA mortality was 65%. Refractory
cardiogenic shock was the leading indication to ECMO implantation,
however ECMO was utilized also as bailout strategy in the context of
intraprocedural complications during TAVI in 10 cases, with a 30%
mortality (3 deaths in 10 cases). Hypothermia protocols were utilized
in 20% of the cases. Stroke prevalence was 16%. The longest length of
support with successful weaning was 192 days, the oldest patient to
survive ECMO was 91 years old and median age of patients who sur-
vived ECMO was 62 years (IQR 49,70).
CONCLUSIONS This is a large data series collected from a single
center over the last two years. These results provide additional evi-
dence to support ECMO as a valid option for hemodynamic support in
patients of a selected age group presenting with profound cardiogenic
shock and respiratory failure.
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BACKGROUND Catheterization techniques can offer percutaneous
way of coronary revascularization (PCI), in complex coronary lesions.
In cath-lab we are able to perform high risk procedures, but we are
still limited with circulatory failure at time of PCI. Commercial cir-
culation supports (Impella, TandemHeart or ECMO) are expensive.
We decided to develop cheap, fully percutaneous and easy to use
way of circulatory support for backup at high risk PCI for conscious
patients.
METHODS We modiﬁed standard tubing set for open extracorporeal
circulation, we get out of the tubing kit venous reservoir and con-
nect it only for priming, deairing system and for getting volume.
Femoral artery was pre-closed by 2x ProGlide sutures and cannu-
lated with 18 F cannula, femoral vein was cannulated with 20-22 F
cannula. Blood from right atrium was drawn to the centrifugal
pump, continue to the oxygenator and through arterial ﬁlter back to
femoral artery (Image). UFH was given and circulation started at ACT
400 sec. For PCI we used contralateral groin, pressure was recorded
from sheat sideport. At the end UFH was reversed to ACT 250 sec,
arterial puncure was closed with sutures, venous with manual
compression.
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mean LV EF was 23.36.9%. All patients had RCA occlusion and se-
vere left main (LMCA) or prox. left anterior descending (LAD) and
circumﬂex artery (RCx) stenosis. Mean EuroScore II was 19.36.,78%.
Only conscious sedation was used, start of circulation was well
tolerated, all patients needed volum expansion 500-1000 ml. PCI was
performed with average 2,1 DES implantation. Mean contrast media
volume was 26544.2 ml. At time of balloon dilatation patients had
only non-pulsatile ﬂow. All patients had weaning at cath-lab, mobi-
lized in 24 hours. Mean drop of hemoglobin was 25,314,6 g/l, no
change in platelets. We found decrease of creatinine by mean
13,88,6 mmol/l. We did not notice leg ischemia, in one case there was
bleeding from puncture site of PCI entry (not circulation site),
resolved with manual compression and 2 units of blood. All patients
are well, at mean FU of 9 months no angina, NYHA II-III.
CONCLUSIONS Use of mini-system in cath-lab is safe and cheap (total
circulation support costs 1000 V) for high risk PCI of conscious pa-
tients with good clinical results. With Proglide system we can manage
patients safely fully percutaneously.
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BACKGROUND Transcatheter techniques are emerging for left atrial
(LA) decompression under extracorporeal membrane oxygenation
(ECMO). We hypothesized that balloon atrial septostomy (BAS) efﬁ-
ciently discharges the LA and that early timing of LA decompression is
associated with left ventricular functional recovery.
METHODS From 2000 to 2014, BAS was performed in 64 patients [32
adults: median age 37.0 (18-72) years, median weight 65.0 (44-86) kg;
32 children: median age 8.0 (0.3-17.9) years, median weight: 29.0 (5.3-
69.9) kg]. Indications for ECMO support included acute myocarditis
(31.2%) and nonmyocarditis cardiac disease, mostly end-stage dilated
cardiomyopathy (32.8%). BAS was required because of pulmonary
edema/hemorrhage and left ventricular distension. Mean balloon
diameter was 21.88.4mm.
RESULTS Adequate LA decompression was achieved in all patients.
Mean LA pressure fell from 24.26.9mmHg to 7.82.6mmHg(p<0.001). Left to right atrial pressure gradient fell from
17.27.1mmHg to 0.090.5mmHg (p<0.001). Echocardiography
showed an unrestrictive left-to-right atrial shunting in all patients.
Improvement of day-1 chest X-ray was observed in 76.6%, clinical
status in 98.4% and pulmonary hemorrhage in 14 of 14 patients.
Complications occurred in 6 (9.4%) patients, represented by pericar-
dial effusion, fast atrial ﬁbrillation, ventricular ﬁbrillation, transient
complete heart block and femoral venous dissection requiring covered
stent placement. In the 37 (57.8%) patients who were successfully
decannulated, median ECMO duration was 9 (4-24) days. After a
median follow-up of 12.3 (0.1-142) months, 34.4% patients died, 15.6%
received a ventricular assist device, 32.8% were transplanted and
56.2% are home discharged and alive. Age <18 years, weight <30 kg,
acute myocarditis, end-stage dilated cardiomyopathy, postoperative
dysfunction, pre-BAS left atrial mean pressure 30 mmHg and ECMO
duration 96 hours prior to BAS were identiﬁed as risk factors for
death or heart transplant.
CONCLUSIONS Percutaneous BAS effectively discharges the left
atrium in both adults and children under venoaterial ECMO. Early BAS
in the ﬁrst 4 days after ECMO placement may help better left ven-
tricular functional recovery.
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BACKGROUND Mortality for patients presenting with acute coro-
nary syndrome (ACS) complicated by ventricular septal defect (VSD)
and cardiogenic shock (CS) is very high. We utilized the
TandemHeart (Cardiac Assist, Pittsburgh, PA) percutaneous left
ventricular assist device (PVAD) as an adjunct to the treatment of
these patients. We aimed to determine the outcomes of PVAD use
in this population.
METHODS From a single center registry of patients undergoing
mechanical support placement for CS, we identiﬁed cases presenting
with ACS associated with a VSD between 2012 and 2014. Baseline
clinical, hemodynamics, echocardiographic data, transfusions re-
quirements, laboratory data, and outcomes were collected.
RESULTS In our institution’s PVAD database, nine patients (mean age
67.37.8, 88.9% male) with post-ACS VSDs and concomitant CS were
identiﬁed. PVAD implantation improved end-organ perfusion with
lower lactate levels 24 hours after implant (2.01.6 vs 0.90.5,
p¼0.01) and improved mean arterial pressure (80.26.5 vs 93.617.7,
p¼0.001). Mean duration of PVAD support was 242528.9 hours. All
patients had PVAD implanted prior to surgical repair. Six patients
survived 30 days into their hospitalization but four survived to
discharge. Four patients underwent surgical repair 73 days after
implant successfully. Three patients were not amenable to percuta-
neous closure. One was treated surgically and two were transitioned
to Syncardia total artiﬁcial heart; one died a month later of sepsis
and the other died 8 months later of multi-organ failure. One patient
died of a stroke while on PVAD. One was transitioned to extracorpo-
real ventricular assist device therapy and died prior to closure. Out of
nine patients, two required transitioning to extracorporeal membrane
oxygenation.
